Pfizer Inc. et al v. Natco Pharma, Inc. et al
| Pfizer Inc., Warner-Lambert Company LLC and PF PRISM IMB B.V. |
| Natco Pharma, Ltd. and Natco Pharma, Inc. |
| 1:2021cv00078 |
| January 26, 2021 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 23, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 16 NOTICE OF SERVICE of (1) Defendants Natco Pharma Inc.s and Natco Pharma, Ltd.s Initial Disclosures under Fed. R. Civ. P. 26(a)(1) and (2) Defendants Natco Pharma Inc.s and Natco Pharma, Ltd.s Initial Disclosures Pursuant to the Delaware Default Standard Paragraph 3 filed by Natco Pharma, Inc., Natco Pharma, Ltd..(Farnan, Kelly) |
ORAL ORDER Setting Teleconference: Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers to initiate the call.( A Telephone Conference is set for 4/16/2021 at 10:00 AM before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 3/23/2021. Associated Cases: 1:20-cv-01392-CFC et al.(nmf)
|
| Filing 15 Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding March 11, 2021 Oral Order - re Oral Order,,. (Dellinger, Megan) |
|
ORAL ORDER: The Court has received the parties' proposed scheduling order. The Court is concerned that the proposed trial date appears to occur after the expiration of the applicable 30-month stay. The exhibit attached to the proposed order makes no mention of the stay. The parties are directed to submit a joint letter no later than March 18, 2021 that addresses the Court's concern. Ordered by Judge Colm F. Connolly on 3/11/2021. Associated Cases: 1:20-cv-01392-CFC et al.(nmf)
|
| Filing 14 PROPOSED ORDER -- [Proposed] Scheduling Order -- by PF Prism IMB B.V., Pfizer Inc., Warner-Lambert Company LLC. (Attachments: #1 Letter to The Honorable Colm F. Connolly)(Dellinger, Megan) |
| The 3/11/2021 Scheduling Conference is cancelled per the filing of the agreed upon proposed scheduling order today.Associated Cases: 1:20-cv-01392-CFC et al.(nmf) |
|
Filing 13
Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 3/11/2021 at 11:00 AM before Judge Colm F. Connolly. Counsel for Plaintiffs shall coordinate the call and email the dial-in information to chambers. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 2/24/2021. Associated Cases: 1:20-cv-01392-CFC et al.(nmf)
|
|
SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney B. Jefferson Boggs, Christopher J. Sorenson, Karen L. Beckman and Andrew O. Larsen filed by Natco Pharma, Inc., Natco Pharma, Ltd. Signed by Judge Colm F. Connolly on 2/18/2021. (fms)
|
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney B. Jefferson Boggs, Christopher J. Sorenson, Karen L. Beckman and Andrew O. Larsen - filed by Natco Pharma, Inc., Natco Pharma, Ltd.. (Delcollo, Renee) |
| Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Natco Pharma, Ltd. for Natco Pharma, Inc. filed by Natco Pharma, Inc., Natco Pharma, Ltd.. (Farnan, Kelly) |
| Filing 10 ANSWER to #1 Complaint, by Natco Pharma, Inc., Natco Pharma, Ltd..(Farnan, Kelly) |
| Filing 9 Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding Request for Scheduling Conference. (Dellinger, Megan) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 8 SUMMONS Returned Executed by Warner-Lambert Company LLC, Pfizer Inc., PF PRISM IMB B.V.. Natco Pharma, Ltd. served on 1/27/2021, answer due 2/17/2021. (Dellinger, Megan) |
| Filing 7 SUMMONS Returned Executed by Warner-Lambert Company LLC, Pfizer Inc., PF PRISM IMB B.V.. Natco Pharma, Inc. served on 1/27/2021, answer due 2/17/2021. (Dellinger, Megan) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for PF PRISM IMB B.V., Warner-Lambert Company LLC filed by PF PRISM IMB B.V., Pfizer Inc., Warner-Lambert Company LLC. (mal) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,723,730 B2. (mal) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 12/16/2020. Date of Expiration of Patent: 02/08/2034.Thirty Month Stay Deadline: * The ANDA is subject to a 30-month stay in In re Palbociclib Patent Litigation MDL No. 19-2912-CFC (D.Del.). (mal) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Filing 1 COMPLAINT filed against Natco Pharma, Inc., Natco Pharma, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3489186.) - filed by Warner-Lambert Company LLC, Pfizer Inc., PF PRISM IMB B.V.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
